Gene · 7555
Papers3,135
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,135
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ameliorating effects of L-carnitine and synbiotic co-supplementation on anthropometric measures and cardiometabolic traits in women with obesity: a randomized controlled clinical trial. | Front Endocrinol (Lausanne) | 2023 | 37929031 | PubTator, text mining | PubMed |
| E4F1 and ZNF148 are transcriptional activators of the -57A > C and wild-type TERT promoter. | Genome Res | 2023 | 37918959 | PubTator, text mining | PubMed |
| Unveiling the growing significance of metabolism in modulating immune cell function: exploring mechanisms and implications; a review. | Ann Med Surg (Lond) | 2023 | 37915697 | PubTator, text mining | PubMed |
| Native low-density lipoproteins are priming signals of the NLRP3 inflammasome/interleukin-1β pathway in human adipose tissue and macrophages. | Sci Rep | 2023 | 37914804 | PubTator, text mining | PubMed |
| Association of Plasma Zinc and Copper with Body Composition, Lipids and Inflammation in a Cross-Sectional General Population Sample from Germany. | Nutrients | 2023 | 37892535 | PubTator, text mining | PubMed |
| Calcifediol: Mechanisms of Action. | Nutrients | 2023 | 37892484 | PubTator, text mining | PubMed |
| The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies. | Cancer Cell Int | 2023 | 37891636 | PubTator, text mining | PubMed |
| Challenges facing repeat expansion identification, characterisation, and the pathway to discovery. | Emerg Top Life Sci | 2023 | 37888797 | PubTator, text mining | PubMed |
| Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer. | Lipids Health Dis | 2023 | 37885013 | PubTator, text mining | PubMed |
| Distinguishing Lysosomal Acid Lipase Deficiency From Familial Hypercholesterolemia. | JACC Case Rep | 2023 | 37869222 | PubTator, text mining | PubMed |
| Exploration of potential targets and mechanisms of naringenin in the treatment of nonalcoholic fatty liver disease through network pharmacology. | Medicine (Baltimore) | 2023 | 37861538 | PubTator, text mining | PubMed |
| miR-3200 accelerates the growth of liver cancer cells by enhancing Rab7A. | Noncoding RNA Res | 2023 | 37860266 | PubTator, text mining | PubMed |
| FoxK1 associated gene regulatory network in hepatic insulin action and its relationship to FoxO1 and insulin receptor mediated transcriptional regulation. | Mol Metab | 2023 | 37852413 | PubTator, text mining | PubMed |
| Lipid metabolism as a target for cancer drug resistance: progress and prospects. | Front Pharmacol | 2023 | 37841917 | PubTator, text mining | PubMed |
| SARS-CoV-2 papain-like protease plays multiple roles in regulating cellular proteins in the endoplasmic reticulum. | J Biol Chem | 2023 | 37838170 | PubTator, text mining | PubMed |
| Lipid droplets in Zika neuroinfection: Potential targets for intervention? | Mem Inst Oswaldo Cruz | 2023 | 37820117 | PubTator, text mining | PubMed |
| Male infertility with muscle weakness: a point of view. | Ann Med Surg (Lond) | 2023 | 37811075 | PubTator, text mining | PubMed |
| Semaphorin 3C promotes de novo steroidogenesis in prostate cancer cells. | Endocr Relat Cancer | 2023 | 37800655 | PubTator, text mining | PubMed |
| Antibody against apolipoprotein-A1, non-alcoholic fatty liver disease and cardiovascular risk: a translational study. | J Transl Med | 2023 | 37798764 | PubTator, text mining | PubMed |
| SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | Cell | 2023 | 37794589 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7555/papers?page=11